Varenicline Tablet, Film Coated
FDA Label NDC 70771-1773

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Varenicline (NDC 70771-1773). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1773-6

Varenicline Tablets, 0.5 mg

56 Tablets

Rx only

0.5 mg Label (B6f2474d F06f 4361 9470 Aa10d06f32fc 01)

0.5 mg Label (B6f2474d F06f 4361 9470 Aa10d06f32fc 01)

NDC 70771-1774-6

Varenicline Tablets, 1 mg

56 Tablets

Rx only

1 mg Label (B6f2474d F06f 4361 9470 Aa10d06f32fc 02)

1 mg Label (B6f2474d F06f 4361 9470 Aa10d06f32fc 02)

* Please review the disclaimer below.